KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

ClearPoint Neuro (CLPT) Return on Equity (2018 - 2025)

ClearPoint Neuro (CLPT) has disclosed Return on Equity for 12 consecutive years, with 1.16% as the latest value for Q4 2025.

  • Quarterly Return on Equity fell 47.0% to 1.16% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.16% through Dec 2025, down 47.0% year-over-year, with the annual reading at 0.96% for FY2025, 14.0% down from the prior year.
  • Return on Equity hit 1.16% in Q4 2025 for ClearPoint Neuro, up from 1.3% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 0.22% in Q2 2021 to a low of 1.3% in Q3 2025.
  • Historically, Return on Equity has averaged 0.64% across 5 years, with a median of 0.57% in 2024.
  • Biggest five-year swings in Return on Equity: skyrocketed 892bps in 2021 and later tumbled -70bps in 2025.
  • Year by year, Return on Equity stood at 0.31% in 2021, then plummeted by -39bps to 0.43% in 2022, then tumbled by -130bps to 0.99% in 2023, then increased by 30bps to 0.7% in 2024, then crashed by -67bps to 1.16% in 2025.
  • Business Quant data shows Return on Equity for CLPT at 1.16% in Q4 2025, 1.3% in Q3 2025, and 1.12% in Q2 2025.